18:24 IST
BSE
Management Change
Mangalam Drugs and Organics Management Change
Manglam Drugs and Organics Ltd. has appointed M/s S.N. Nanda & Co. as Statutory Auditor and M/s L.N. Joshi & Co. as Secretarial Auditor.
Mangalam Drugs and Organics Ltd
- Share price
- ₹33.09
- Market cap
- ₹52.38 Cr
- Revenue (annual)
- ₹232.1 Cr
- Net profit (annual)
- ₹-44.40 Cr
- P/E (TTM)
- -1.4×Sector 47.3×
- Promoter holding
- 35.65%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Share Pledge 5Other Announcement 5Debt & Borrowing 5Management Change 4Financial Results 3Board Meeting Date 3Annual General Meeting 3Legal & Regulatory 2Adverse Business Impact 2Board Meeting Outcome 1
Time
4 announcements with these filters
16:33 IST
BSE
Management Change
Mangalam Drugs and Organics Management Change
Mangalam Drugs and Organics Limited has appointed Mr. Prabhakar Raghunath Zavar as a Non-Executive Independent Director, effective September 15, 2026.
17:56 IST
BSE
Management Change
Mangalam Drugs and Organics Management Change
Mangalam Drugs and Organics Limited announced the cessation of its Secretarial Auditor, M/s. Ragini Chokshi & Co., due to resignation effective August 4, 2026.
12:54 IST
BSE
Management Change
Mangalam Drugs and Organics Management Change
Mangalam Drugs and Organics Limited announced the resignation of Ms. Anuradha Pandey as Company Secretary and Compliance Officer, effective March 29, 2026. She resigned to pursue opportunities outside the company. The filing includes an explanation for a slight delay in disclosure due to administrative oversight.